US Bancorp’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.08M | Buy |
47,170
+6,467
| +16% | +$703K | 0.01% | 521 |
|
|
2026
Q1 | $3.76M | Sell |
40,703
-1,043
| -2% | -$105K | ﹤0.01% | 674 |
|
|
2025
Q4 | $4.26M | Buy |
41,746
+9,660
| +30% | +$864K | 0.01% | 647 |
|
|
2025
Q3 | $2M | Sell |
32,086
-1,960
| -6% | -$107K | ﹤0.01% | 877 |
|
|
2025
Q2 | $1.77M | Sell |
34,046
-2,652
| -7% | -$118K | ﹤0.01% | 895 |
|
|
2025
Q1 | $1.56M | Buy |
36,698
+3,876
| +12% | +$167K | ﹤0.01% | 937 |
|
|
2024
Q4 | $1M | Sell |
32,822
-200
| -0.6% | -$5.63K | ﹤0.01% | 1119 |
|
|
2024
Q3 | $758K | Buy |
33,022
+8,346
| +34% | +$236K | ﹤0.01% | 1271 |
|
|
2024
Q2 | $713K | Sell |
24,676
-8,821
| -26% | -$205K | ﹤0.01% | 1280 |
|
|
2024
Q1 | $691K | Sell |
33,497
-4,579
| -12% | -$98.2K | ﹤0.01% | 1299 |
|
|
2023
Q4 | $1.03M | Buy |
38,076
+25,832
| +211% | +$678K | ﹤0.01% | 1101 |
|
|
2023
Q3 | $363K | Sell |
12,244
-812
| -6% | -$28.6K | ﹤0.01% | 1534 |
|
|
2023
Q2 | $467K | Buy |
13,056
+2,299
| +21% | +$66K | ﹤0.01% | 1437 |
|
|
2023
Q1 | $252K | Buy |
10,757
+788
| +8% | +$22.5K | ﹤0.01% | 1754 |
|
|
2022
Q4 | $271K | Sell |
9,969
-5,279
| -35% | -$242K | ﹤0.01% | 1700 |
|
|
2022
Q3 | $821K | Buy |
15,248
+1,891
| +14% | +$97.1K | ﹤0.01% | 1141 |
|
|
2022
Q2 | $538K | Buy |
13,357
+549
| +4% | +$27.2K | ﹤0.01% | 1401 |
|
|
2022
Q1 | $849K | Buy |
12,808
+632
| +5% | +$43.3K | ﹤0.01% | 1261 |
|
|
2021
Q4 | $1.22M | Buy |
12,176
+1,932
| +19% | +$200K | ﹤0.01% | 1119 |
|
|
2021
Q3 | $1.28M | Buy |
10,244
+3,489
| +52% | +$415K | ﹤0.01% | 1067 |
|
|
2021
Q2 | $839K | Buy |
6,755
+315
| +5% | +$42.4K | ﹤0.01% | 1289 |
|
|
2021
Q1 | $982K | Buy |
6,440
+4,662
| +262% | +$705K | ﹤0.01% | 1147 |
|
|
2020
Q4 | $230K | Buy |
1,778
+140
| +9% | +$16.1K | ﹤0.01% | 1817 |
|
|
2020
Q3 | $183K | Buy |
1,638
+153
| +10% | +$14K | ﹤0.01% | 1814 |
|
|
2020
Q2 | $121K | Sell |
1,485
-606
| -29% | -$48.8K | ﹤0.01% | 2004 |
|
|
2020
Q1 | $146K | Buy |
2,091
+1,195
| +133% | +$91.7K | ﹤0.01% | 1829 |
|
|
2019
Q4 | $70K | Buy |
896
+1
| +0.1% | +$72 | ﹤0.01% | 2329 |
|
|
2019
Q3 | $57K | Buy |
895
+845
| +1,690% | +$74.4K | ﹤0.01% | 2394 |
|
|
2019
Q2 | $4K | Buy |
+50
| New | +$3.82K | ﹤0.01% | 3318 |
|
Other funds holding GH
DTC
US Bancorp's GH Position: Q2 2026 in Review
US Bancorp increased its Guardant Health (GH) stake by 16% in Q2 2026, buying an estimated $703K and bringing the position to 47,170 shares worth $7.08M. The position accounts for 0.01% of the portfolio, ranked #521.
US Bancorp first reported a position in GH in Q2 2019 and has held it in 29 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- US Bancorp held 47,170 shares of Guardant Health worth $7.08M as of Q2 2026.
- US Bancorp bought 6,467 Guardant Health shares in Q2 2026, an estimated $703K.
- Guardant Health made up 0.01% of US Bancorp's portfolio in Q2 2026, its #521 holding.
- US Bancorp first reported a position in Guardant Health in Q2 2019 and has held it in 29 quarters since.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.